+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Autologous Stem Cell & Non-Stem Cell Based Therapies Market Research Report by Type, Application, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 259 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4995357
UP TO OFF until Dec 31st 2022
The Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market size was estimated at USD 5,463.66 million in 2021, USD 6,256.31 million in 2022, and is projected to grow at a CAGR 14.68% to reach USD 12,431.29 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Autologous Stem Cell & Non-Stem Cell Based Therapies to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Autologous Non-Stem Cells and Autologous Stem Cells.
  • Based on Application, the market was studied across Cancer, Cardiovascular Disease, Neurodegenerative Disorders, Orthopedic Diseases, and Others.
  • Based on End-User, the market was studied across Ambulatory Surgical Centers, Hospitals, and Research Facilities.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Autologous Stem Cell & Non-Stem Cell Based Therapies market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Autologous Stem Cell & Non-Stem Cell Based Therapies Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market, including Antria, Inc, Bioheart, Inc, Brainstorm Cell Therapeutics, Inc, Caladrius Biosciences Inc., Castle Creek Biosciences Inc., Cytori Therapeutics, Inc., Dendreon Corporation, Fibrocell, Genesis Biopharma, Georgia Health Sciences University, Gilead Sciences Inc., Neostem, Novartis AG, Opexa Therapeutics, Orgenesis, Pharmicell Co. Ltd, Regeneus, Regenexx, Tengion, TiGenix, U.S. Stem Cell, Inc., and VIRxSYS Corporation.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
4. What is the competitive strategic window for opportunities in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
5. What are the technology trends and regulatory frameworks in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
6. What is the market share of the leading vendors in the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?
7. What modes and strategic moves are considered suitable for entering the Global Autologous Stem Cell & Non-Stem Cell Based Therapies Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of cancer and diabetes
5.1.1.2. Increased in demand due to ability to treat a large number of infectious diseases
5.1.1.3. Advantage of intensive therapy for older patients
5.1.2. Restraints
5.1.2.1. Lack of a significant therapeutic graft-versus-tumor effect
5.1.2.2. Chances of cells contamination with bacteria
5.1.3. Opportunities
5.1.3.1. Rise in investment for extensive research and development
5.1.3.2. Advances in treating various diseases neurodegenerative diseases and macular degeneration
5.1.4. Challenges
5.1.4.1. Risks and complications associated with the therapy
5.2. Cumulative Impact of COVID-19
6. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Type
6.1. Introduction
6.2. Autologous Non-Stem Cells
6.3. Autologous Stem Cells
7. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by Application
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disease
7.4. Neurodegenerative Disorders
7.5. Orthopedic Diseases
7.6. Others
8. Autologous Stem Cell & Non-Stem Cell Based Therapies Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals
8.4. Research Facilities
9. Americas Autologous Stem Cell & Non-Stem Cell Based Therapies Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Autologous Stem Cell & Non-Stem Cell Based Therapies Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Autologous Stem Cell & Non-Stem Cell Based Therapies Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Antria, Inc
13.2. Bioheart, Inc
13.3. Brainstorm Cell Therapeutics, Inc
13.4. Caladrius Biosciences Inc.
13.5. Castle Creek Biosciences Inc.
13.6. Cytori Therapeutics, Inc.
13.7. Dendreon Corporation
13.8. Fibrocell
13.9. Genesis Biopharma
13.10. Georgia Health Sciences University
13.11. Gilead Sciences Inc.
13.12. Neostem
13.13. Novartis AG
13.14. Opexa Therapeutics
13.15. Orgenesis
13.16. Pharmicell Co. Ltd
13.17. Regeneus
13.18. Regenexx
13.19. Tengion
13.20. TiGenix
13.21. U.S. Stem Cell, Inc.
13.22. VIRxSYS Corporation
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET DYNAMICS
FIGURE 8. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2027
FIGURE 11. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2027
FIGURE 18. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 29. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2027
FIGURE 31. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 39. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2027
FIGURE 41. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2027
FIGURE 49. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 51. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2027
FIGURE 53. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 67. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2027
FIGURE 68. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 80. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 81. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS NON-STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AUTOLOGOUS STEM CELLS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY NEURODEGENERATIVE DISORDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY ORTHOPEDIC DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY OTHERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY RESEARCH FACILITIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 61. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 63. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 65. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 66. ARGENTINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 67. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 69. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 70. BRAZIL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 71. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 73. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 74. CANADA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 75. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 77. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 78. MEXICO AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 81. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 83. UNITED STATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 86. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 87. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 89. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 91. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 92. AUSTRALIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 93. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 95. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 96. CHINA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 97. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 99. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 100. INDIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 101. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 103. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 104. INDONESIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 105. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 107. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 108. JAPAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 109. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 111. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 112. MALAYSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 113. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 114. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 115. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. PHILIPPINES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 117. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 118. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 119. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 120. SINGAPORE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 121. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 122. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 123. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 124. SOUTH KOREA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 125. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 126. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 127. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 128. TAIWAN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 129. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 130. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 131. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 132. THAILAND AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 138. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 139. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 140. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 141. FRANCE AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 142. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 144. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 145. GERMANY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 146. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 147. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 148. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 149. ITALY AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 150. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 151. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 152. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 153. NETHERLANDS AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 154. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 156. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 157. QATAR AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 158. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 159. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 160. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 161. RUSSIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 162. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 163. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 164. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 165. SAUDI ARABIA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 166. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 168. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 169. SOUTH AFRICA AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 170. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 171. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 172. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 173. SPAIN AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 178. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 180. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 181. UNITED KINGDOM AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 182. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 183. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 184. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 185. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET RANKING
TABLE 186. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET SHARE, BY KEY PLAYER, 2021
TABLE 187. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET MERGER & ACQUISITION
TABLE 188. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 189. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 190. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET INVESTMENT & FUNDING
TABLE 191. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 192. GLOBAL AUTOLOGOUS STEM CELL & NON-STEM CELL BASED THERAPIES MARKET: LICENSE & PRICING

Companies Mentioned

  • Antria, Inc
  • Bioheart, Inc
  • Brainstorm Cell Therapeutics, Inc
  • Caladrius Biosciences Inc.
  • Castle Creek Biosciences Inc.
  • Cytori Therapeutics, Inc.
  • Dendreon Corporation
  • Fibrocell
  • Genesis Biopharma
  • Georgia Health Sciences University
  • Gilead Sciences Inc.
  • Neostem
  • Novartis AG
  • Opexa Therapeutics
  • Orgenesis
  • Pharmicell Co. Ltd
  • Regeneus
  • Regenexx
  • Tengion
  • TiGenix
  • U.S. Stem Cell, Inc.
  • VIRxSYS Corporation

Methodology

Loading
LOADING...